Stem Cells and Reprogramming
joint with Engineering Cell Fate and Function
Organizer(s): Deepak Srivastava and Shinya YamanakaDate: April 06 - 11, 2014
Location: Resort at Squaw Creek, Olympic Valley, CA, USA
The fields of developmental and stem cell biology have revealed complex networks that regulate fundamental cell fate decisions. Such information was leveraged first to reprogram cells to induced pluripotent stem cells, and more recently to induce cell fate transitions from one somatic cell state directly into another, without involving a pluripotent stem cell phase. This conference will focus on the mechanisms underlying cellular pluripotency, differentiation, and reprogramming. These will include the understanding of signaling, transcriptional, translational and epigenetic events regulating cell fate transitions. The utility of such cellular regulation for disease modeling and regenerative medicine for multiple organ systems will be examined. Translational efforts in academic and industry that are moving toward regenerative medicine will be highlighted, as will efforts to use stem cell biology for drug discovery and evaluating drug toxicity. The emerging intersection of human genetics and stem cell biology that will lead to more personalized medicine will be a thematic focus woven into most sessions of this conference.
Scholarship Deadline: December 10 2013
Discounted Abstract Deadline: December 10 2013
Abstract Deadline: January 15 2014
Discounted Registration Deadline: February 6 2014
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Sangamo BioSciences, Inc.
Jeffrey M. Gimble Scholarship
We gratefully acknowledge the generous grant for this conference provided by:Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Grant No. 1R13HD079122-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.